Inaktiver Wert

Andere Sprachen PERRIGO TEL AVIV STOCK EXCHANGE

Aktien

Schlusskurs TEL AVIV STOCK EXCHANGE Andere Börsenplätze
- ^ILa	-

13.06.	PERRIGO COMPANY PLC : Piper Sandler bekräftigt seine Kaufempfehlung	ZM
11.06.	Transcript : Perrigo Company plc Presents at Oppenheimer's 24th Annual Virtual Consumer Growth and E-Commerce Conference, Jun-11-2024 01:30 PM

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Perrigo Company plc Appoints Todd Penegor as Member of Board and to Serve on Audit Committee, Effective June 21, 2024	10.06.
Perrigo to Attend Oppenheimer 24th Annual Consumer Growth and E-Commerce Conference	29.05.
Perrigo Company plc Announces Executive Changes	28.05.
Perrigo to Attend Oppenheimer 24th Annual Consumer Growth & E-Commerce Conference	28.05.
Perrigo's Q1 Adjusted Earnings, Net Sales Drop	07.05.
Earnings Flash (PRGO) PERRIGO COMPANY Posts Q1 Revenue $1.08B	07.05.
Earnings Flash (PRGO) PERRIGO COMPANY Posts Q1 EPS $0.29, vs. Street Est of $0.23	07.05.
Perrigo: Q1 Earnings Snapshot	07.05.
Perrigo Company plc Reports Earnings Results for the First Quarter Ended March 30, 2024	07.05.
Perrigo Company plc Reaffirms Earnings Guidance Year 2024 and Provides Sales Guidance for the Second Half of 2024	07.05.
Perrigo Announces Executive Transition for Its Consumer Self-Care International Business	07.05.
Perrigo Keeps Quarterly Dividend at $0.276 Per Share; Payable June 18 to Shareholders on May 31	01.05.
Perrigo Announces Quarterly Dividend	01.05.
Perrigo Company plc Announces Quarterly Dividend, Payable on June 18, 2024	01.05.
Sector Update: Health Care Stocks Decline Late Afternoon	25.04.
Perrigo Receives Binding Offer to Sell HRA Pharma Rare Diseases Business for Up to $295 Million	25.04.
Perrigo Receives Binding Offer to Divest its HRA Pharma Rare Diseases Business for up to €275 Million	25.04.
Esteve Healthcare S.L. signed a binding offer to acquire HRA Pharma Rare Diseases America, LLC from Perrigo Company plc for approximately ?280 million.	25.04.
Perrigo to Release First Quarter 2024 Financial Results on May 7, 2024	23.04.
Opill and WNBA Team Up for Groundbreaking Partnership	09.04.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen PERRIGO TEL AVIV STOCK EXCHANGE

Aktien

Andere Sprachen

Filter